Peter D. Friedmann

13.3k total citations · 2 hit papers
237 papers, 9.7k citations indexed

About

Peter D. Friedmann is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Peter D. Friedmann has authored 237 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Epidemiology, 119 papers in Public Health, Environmental and Occupational Health and 83 papers in General Health Professions. Recurrent topics in Peter D. Friedmann's work include Substance Abuse Treatment and Outcomes (121 papers), Opioid Use Disorder Treatment (101 papers) and HIV, Drug Use, Sexual Risk (42 papers). Peter D. Friedmann is often cited by papers focused on Substance Abuse Treatment and Outcomes (121 papers), Opioid Use Disorder Treatment (101 papers) and HIV, Drug Use, Sexual Risk (42 papers). Peter D. Friedmann collaborates with scholars based in United States, United Kingdom and France. Peter D. Friedmann's co-authors include Michael D. Stein, Stephenie C. Lemon, Richard Saitz, Dean R. Gerstein, Thomas D’Aunno, Marshall H. Chin, Jason Roy, Melissa A. Clark, William Rakowski and Anne W. Moulton and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Peter D. Friedmann

225 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patients’ use of the internet for medical information

2002 786 citations Peter D. Friedmann et al. profile →
Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression

2003 682 citations Peter D. Friedmann et al. profile →

Peers

Countries citing papers authored by Peter D. Friedmann

Since Specialization

Citations

This map shows the geographic impact of Peter D. Friedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Friedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Friedmann more than expected).

Fields of papers citing papers by Peter D. Friedmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Friedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Friedmann. The network helps show where Peter D. Friedmann may publish in the future.

Co-authorship network of co-authors of Peter D. Friedmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Friedmann. A scholar is included among the top collaborators of Peter D. Friedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Friedmann. Peter D. Friedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Barriers to accessing medications for opioid use disorder among rural individuals 2025 ·International Journal of Drug Policy ·Anna M. Morenz, Robin M. Nance, (unknown), Judith Feinberg, Gordon S. Smith, P. Todd Korthuis, Mai T. Pho, Wiley D. Jenkins, Peter D. Friedmann, Thomas J. Stopka, Laura Fanucchi, William C. Miller, Vivian F. Go, Ryan P. Westergaard, David W. Seal, William A. Zule, Heidi M. Crane, Joseph A. Delaney, Judith I. Tsui	4
2	Cost analysis of MOUD implementation and sustainability in Massachusetts jails 2025 ·Health & Justice ·(unknown), (unknown), Elizabeth Evans, (unknown), (unknown), Peter D. Friedmann, (unknown), Sean M. Murphy	0
3	Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance 2024 ·Journal of Viral Hepatitis ·Damien C. Tully, Karen A. Power, (unknown), Thomas J. Stopka, Peter D. Friedmann, P. Todd Korthuis, Hannah L. F. Cooper, April M. Young, David W. Seal, Ryan P. Westergaard, Todd M. Allen	1
4	Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails 2024 ·JAMA Network Open ·(unknown), Lori J. Ducharme, Bruce G. Taylor, Phoebe A. Lamuda, Marynia Kolak, Peter D. Friedmann, Harold A. Pollack, John A. Schneider	14
5	Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States 2024 ·Viruses ·(unknown), (unknown), Patrick F. Dowd, Kathleen M. Mazor, Thomas J. Stopka, Peter D. Friedmann	2
6	More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment Study 2024 ·Viruses ·(unknown), (unknown), (unknown), Thomas J. Stopka, Randall Hoskinson, Patrick F. Dowd, Peter D. Friedmann	3
7	Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study 2024 ·Social Science & Medicine ·Thomas J. Stopka, (unknown), Gillian Leichtling, (unknown), (unknown), (unknown), (unknown), Patrick F. Dowd, Suzan M. Walters, April M. Young, William A. Zule, Peter D. Friedmann, Vivian F. Go, Robin Baker, Rob J. Fredericksen	16
8	Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances 2024 ·PubMed ·(unknown), Bridget M. Whitney, Wiley D. Jenkins, Thomas J. Stopka, P. Todd Korthuis, Lydia N. Drumright, (unknown), Peter D. Friedmann, Mai T. Pho, April M. Young, Ryan P. Westergaard, David W. Seal, Vivian F. Go, William C. Miller, William A. Zule, Judith Feinberg, Hannah L. F. Cooper, Judith I. Tsui, Heidi M. Crane, Joseph A. Delaney	0
9	Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers 2024 ·Journal of Addiction Medicine ·Ekaterina Pivovarova, (unknown), Peter D. Friedmann, Thomas J. Stopka, (unknown), Elizabeth Evans	0
10	Parental substance use and home visiting programs: Implementation considerations for relationship‐based treatment 2023 ·Infant Mental Health Journal ·(unknown), Nancy E. Suchman, Nancy Byatt, Emily Feinberg, Peter D. Friedmann, Elizabeth Peacock‐Chambers	8
11	Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities 2023 ·International Journal of Drug Policy ·(unknown), William C. Miller, David Kline, Bridget M. Whitney, April M. Young, P. Todd Korthuis, Thomas J. Stopka, Judith Feinberg, William A. Zule, Mai T. Pho, Peter D. Friedmann, Ryan P. Westergaard, (unknown), (unknown), (unknown), Vivian F. Go, Kathryn E. Lancaster	4
12	“I am not a junkie”: Social categorization and differentiation among people who use drugs 2023 ·International Journal of Drug Policy ·(unknown), Robin Baker, Ximena A. Levander, (unknown), Suzan M. Walters, (unknown), (unknown), (unknown), (unknown), (unknown), Samuel L. Chen, Patrick F. Dowd, (unknown), Peter D. Friedmann, Rob J. Fredericksen, David W. Seal, Vivian F. Go	9
13	Relation of Patient's Opinion of Alcohol's Health Effects and Drinking Habits Among Hospitalized Patients With Cardiovascular Disease 2022 ·The American Journal of Cardiology ·(unknown), (unknown), (unknown), (unknown), (unknown), Peter D. Friedmann, Timothy S. Naimi, Quinn R. Pack	5
14	Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers 2022 ·International Journal of Drug Policy ·Thomas J. Stopka, (unknown), Warren J. Ferguson, Ekaterina Pivovarova, (unknown), Peter D. Friedmann, Elizabeth Evans	28
15	Preoperative alcohol interventions for elective surgical patients: Results from a randomized pilot trial 2022 ·Surgery ·Anne C. Fernandez, (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer F. Waljee, Peter D. Friedmann, Michael J. Mello, Brian Borsari, Frederic C. Blow	5
16	Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders 2016 ·New England Journal of Medicine ·Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, Edward V. Nunes, Tamara Y. Boney, Randall Hoskinson, Donna Wilson, Ryan McDonald, John Rotrosen, Marc N. Gourevitch, Michael Gordon, Marc Fishman, Donna T. Chen, Richard J. Bonnie, James Cornish, Sean M. Murphy, Charles P. O’Brien	225
17	Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. 2014 ·PubMed ·Tae Woo Park, Peter D. Friedmann	7
18	Psychostimulant-Related Deaths Among Former Inmates 2011 ·Journal of Addiction Medicine ·Susan L. Calcaterra, Patrick J. Blatchford, Peter D. Friedmann, Ingrid A. Binswanger	8
19	Receipt of Disability Payments by Substance Users: Mental and Physical Health Correlates 2006 ·American Journal on Addictions ·Michael D. Stein, Bradley J. Anderson, (unknown), Peter D. Friedmann	6
20	Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? 2000 ·PubMed ·Peter D. Friedmann, Thomas D’Aunno, Lei Jin, Jeffrey A. Alexander	118

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact